Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Equipe Genetique des Anomalies du Developpement, |
RCV001358690 | SCV001554501 | uncertain significance | Early-onset myopathy with fatal cardiomyopathy | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV003169778 | SCV003856804 | uncertain significance | Cardiovascular phenotype | 2022-12-07 | criteria provided, single submitter | clinical testing | The c.47565_47572delCTCCAGGGinsAC variant, located in coding exon 153 of the TTN gene, results from an in-frame deletion of CTCCAGGG and insertion of AC at nucleotide positions 47565 to 47572. This results in the substitution of the residue for a histidine residue at codon 15856, an amino acid with highly similar properties. This amino acid region is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Clinical Genetics Laboratory, |
RCV004697119 | SCV005198624 | uncertain significance | not provided | 2022-05-27 | criteria provided, single submitter | clinical testing |